DA
MGNX icon

Denali Advisors’s MacroGenics MGNX Stock Holding History

Denali Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,300
Closed -$20K – 485
2023
Q3 		$20K Hold
4,300
– – 0.01% 340
2023
Q2 		$23K Hold
4,300
– – 0.01% 331
2023
Q1 		$30.8K Sell
4,300
-3,000
-41% -$18.1K 0.01% 263
2022
Q4 		$49K Hold
7,300
– – 0.02% 224
2022
Q3 		$25K Buy
+7,300
New +$27.9K 0.01% 272

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Denali Advisors's MGNX Position: Q4 2023 in Review

Denali Advisors sold out of MacroGenics (MGNX) in Q4 2023, closing a stake of 4,300 shares — an estimated $20K sold.

Denali Advisors first reported a position in MGNX in Q3 2022 and held it in 5 quarters. The position peaked at $49K in Q4 2022. 142 funds tracked by Wall St. Rank hold MGNX as of Q4 2023.

  • Denali Advisors reported no remaining MacroGenics position as of Q4 2023 after selling out during the quarter.
  • Denali Advisors sold 4,300 MacroGenics shares in Q4 2023, an estimated $20K.
  • Denali Advisors first reported a position in MacroGenics in Q3 2022 and held it in 5 quarters.
  • Denali Advisors's MacroGenics position peaked at $49K in Q4 2022.
  • 142 funds tracked by Wall St. Rank held MacroGenics as of Q4 2023.

Based on Denali Advisors's 13F filing for Q4 2023, filed 19 Jan 2024.